Literature DB >> 16271343

Refining molecular analysis in the pathways of colorectal carcinogenesis.

Andrew Rowan1, Sarah Halford, Michelle Gaasenbeek, Zoe Kemp, Oliver Sieber, Emmanouil Volikos, Eleanor Douglas, Heike Fiegler, Nigel Carter, Ian Talbot, Andrew Silver, Ian Tomlinson.   

Abstract

BACKGROUND & AIMS: In the stepwise model, specific genetic and epigenetic changes accumulate as colorectal adenomas progress to carcinomas (CRCs). CRCs also acquire global phenotypes, particularly microsatellite instability (MSI) and aneuploidy/polyploidy (chromosomal instability, CIN). Few changes specific to MSI-low or CIN+ cancers have been established.
METHODS: We investigated 100 CRCs for: mutations and loss of heterozygosity (LOH) where appropriate, of APC, K-ras, BRAF, SMAD4, and p53; deletion on 5q around APC and 18q around SMAD4; total chromosomal-scale losses and gains; MSI; and CIN.
RESULTS: As expected, CIN- cancers had fewer chromosomal changes overall than CIN+ lesions, but after correcting for this, 5q deletions alone predicted CIN+ status. 5q deletions were not, however, significantly associated with APC mutations, which were equally frequent in CIN+ and CIN- tumors. We therefore found no evidence to show that mutant APC promotes CIN. p53 mutations/LOH were more common in CIN+ than CIN- lesions, and all chromosomal amplifications were in CIN+ tumors. CIN- cancers could be subdivided according to the total number of chromosomal-scale changes into CIN-low and CIN-stable groups; 18q deletion was the best predictor, being present in nearly all CIN-low lesions and almost no CIN-stable tumors. MSI-low was not associated with CIN, any specific mutation, a mutational signature, or clinicopathologic characteristic.
CONCLUSIONS: Overall, the components of the stepwise model (APC, K-ras, and p53 mutations, plus 18q LOH) tended to co-occur randomly. We propose an updated version of this model comprising 4 pathways of CRC pathogenesis, on the basis of 5q/18q deletions, MSI (high/low), and CIN (high/low/stable).

Entities:  

Mesh:

Year:  2005        PMID: 16271343     DOI: 10.1016/s1542-3565(05)00618-x

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  22 in total

Review 1.  Molecular classification and correlates in colorectal cancer.

Authors:  Shuji Ogino; Ajay Goel
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

2.  Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.

Authors:  Lenora W M Loo; Maarit Tiirikainen; Iona Cheng; Annette Lum-Jones; Ann Seifried; James M Church; Robert Gryfe; Daniel J Weisenberger; Noralane M Lindor; Steven Gallinger; Robert W Haile; David J Duggan; Stephen N Thibodeau; Graham Casey; Loïc Le Marchand
Journal:  Genes Chromosomes Cancer       Date:  2013-01-23       Impact factor: 5.006

Review 3.  The chromosomal instability pathway in colon cancer.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

4.  A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data.

Authors:  Christopher Yau; Dmitri Mouradov; Robert N Jorissen; Stefano Colella; Ghazala Mirza; Graham Steers; Adrian Harris; Jiannis Ragoussis; Oliver Sieber; Christopher C Holmes
Journal:  Genome Biol       Date:  2010-09-21       Impact factor: 13.583

5.  DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.

Authors:  Robert N Jorissen; Lara Lipton; Peter Gibbs; Matthew Chapman; Jayesh Desai; Ian T Jones; Timothy J Yeatman; Philip East; Ian P M Tomlinson; Hein W Verspaget; Lauri A Aaltonen; Mogens Kruhøffer; Torben F Orntoft; Claus Lindbjerg Andersen; Oliver M Sieber
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

Review 6.  Genetic prognostic and predictive markers in colorectal cancer.

Authors:  Axel Walther; Elaine Johnstone; Charles Swanton; Rachel Midgley; Ian Tomlinson; David Kerr
Journal:  Nat Rev Cancer       Date:  2009-06-18       Impact factor: 60.716

7.  The in vivo rate of somatic adenomatous polyposis coli mutation.

Authors:  Chris Hornsby; Karen M Page; Ian Tomlinson
Journal:  Am J Pathol       Date:  2008-03-05       Impact factor: 4.307

8.  Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia.

Authors:  Mathew A Sloane; Jason W H Wong; Dilmi Perera; Andrea C Nunez; John E Pimanda; Nicholas J Hawkins; Oliver M Sieber; Michael J Bourke; Luke B Hesson; Robyn L Ward
Journal:  Epigenetics       Date:  2014-05-16       Impact factor: 4.528

Review 9.  Establishing a biological profile for interval colorectal cancers.

Authors:  Amy L Cisyk; Harminder Singh; Kirk J McManus
Journal:  Dig Dis Sci       Date:  2014-05-20       Impact factor: 3.199

10.  Use of multivariate analysis to suggest a new molecular classification of colorectal cancer.

Authors:  Enric Domingo; Rajarajan Ramamoorthy; Dahmane Oukrif; Daniel Rosmarin; Michal Presz; Haitao Wang; Hannah Pulker; Helen Lockstone; Tarjei Hveem; Treena Cranston; Havard Danielsen; Marco Novelli; Brian Davidson; Zheng-Zhou Xu; Peter Molloy; Elaine Johnstone; Christopher Holmes; Rachel Midgley; David Kerr; Oliver Sieber; Ian Tomlinson
Journal:  J Pathol       Date:  2013-02       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.